The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 338:910-912 March 26, 1998 Number 13
NextNext

The CDKN2A Tumor-Suppressor Locus — A Tale of Two Proteins

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Monzon, J.
-PubMed Citation
In this issue of the Journal, Monzon et al. report the occurrence of germ-line mutations of the CDKN2A gene in patients with multiple primary melanomas.1 CDKN2A, a tumor-suppressor gene, has a central role in regulating cell division.

The loss of function of tumor-suppressor genes is a key event in the multistep process that transforms a normal cell into a cancer cell. In normal cells, the proteins that arise from these genes participate in diverse biologic processes. Some proteins, such as the p53 protein, protect the cell from genetic damage, and their loss leads to the characteristic genomic instability and . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.